Medicines Price Control
1.1.1 Continuous monitoring, information management and dissemination on different price control mechanisms and policies and their impacts
Only some countries in the region have transparent price control mechanisms and policies. HAIAP will continue to monitor different price control mechanisms (or the lack of it). The information gathered on either the regressive or progressive policies in countries will be collated and disseminated to all stakeholders such as members of HAIAP, key contacts and other NGOs already working in the same priority areas, health ministry officials, other relevant government officials, academia, other activists and the general public.
Recent Events
PSSL’s 40th Anniversary Annual Sessions – Developing Pharmacy Practice: the Cornerstone of Pharmaceutical Care, Colombo, Sri Lanka
Related Network News
- Press Release: Defend Affordable Drug Treatment in India – International Coalition Demands Protection of Generics
- Coalition Against Bayer-Dangers: Health groups defend affordable drug treatment in India – http://www.cbgnetwork.org/2793.html
- People’s Health Movement: Health groups call on German drug-maker Bayer to cancel the suit against the Indian government – http://www.phmovement.org/cms/en/node/1142
1.1.2 Initiate research on comparative medicines prices in the region and inaccessibility due to high medicine prices
Comparing medicines prices within regions is an essential tool for advocacy and lobbying. Also important is the documentation of lack of accessibility and non-compliance with prescribed medication as a result of high medicines prices. Therefore, HAIAP will initiate continuous monitoring of comparative medicines prices and the lack of accessibility of medicines due to high prices. The results will be distributed to all stakeholders and target groups, thus creating awareness for effective lobbying of governments to introduces mechanisms to increase the affordability of medicines.